|Most Recent Exit||In Price/Share||Average Out Price/Share|
Horizon Discovery is a world leader in the application of gene editing technologies, which are used for research into, and treatment of, genetically-based diseases.
Calculus Capital exited its holding in 2016, via a placement of shares on the AIM. The average exit multiple for sale of the shares was 1.82x, constituting a tax free return of over 160%, when factoring in initial investor income tax relief of 30%. The investment was held for 3 years, 3 months.